Haemonetics Corp. (HAE)

Low worldwide penetration combined with demand outstripping supply makes a positive long-term thesis for investing in the blood processing and supply chain management industry. Haemonetics Corp. (HAE - Analyst Report) has benefited from recent acquisitions that have added novel technologies.

Additionally, recent supply agreements and double-digit growth demonstrate HAE's strong market position in a growing industry.